Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators
20 nov. 2023 11h45 HE
|
Pixium Vision
Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators Paris, France, November 20, 2023 – 5:45 pm (CET) – Pixium Vision SA (Euronext Growth...
Latest Top500 List Highlights Several World's Fastest and Most Efficient Supercomputers Powered by AMD
14 nov. 2023 09h00 HE
|
Advanced Micro Devices, Inc.
SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) showcased its continued leadership in high performance computing (HPC) at Supercomputing 23. AMD EPYC™ processors and...
Pixium Vision annonce les résultats de l'essai à 48 mois sur la DMLA atrophique sévère
14 nov. 2023 01h00 HE
|
Pixium Vision
Pixium Vision annonce les résultats de l'essai à 48 mois sur la DMLA atrophique sévère L'étude vient confirmer les résultats à 36 mois : l’utilisation de la prothèse sous-rétinienne est possible,...
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
14 nov. 2023 01h00 HE
|
Pixium Vision
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Study confirms subretinal prothesis feasible and well-tolerated with no reduction of natural peripheral vision, confirming...
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
09 nov. 2023 12h58 HE
|
RetinalGeniX Technologies, Inc.
RetinalGeniX Announces Therapeutic Solutions Being Developed for Dry Age-Related Macular Degeneration
and Alzheimer’s Syndrome.
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device
08 nov. 2023 05h45 HE
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC and AVANIA CRO CONTRACT to GUIDE the DEVELOPMENT of TWO DRUG THERAPIES and the RETINALCAM™ IMAGE VISUALIZATION DEVICE
AMD Reports Third Quarter 2023 Financial Results
31 oct. 2023 16h15 HE
|
Advanced Micro Devices, Inc.
SANTA CLARA, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced revenue for the third quarter of 2023 of $5.8 billion, gross margin of 47%, operating income of $224 million,...
RetinalGeniX IRB Approved to Conduct Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
30 oct. 2023 14h51 HE
|
RetinalGeniX Technologies, Inc.
Proposed patient selection process is intended to reduce the cost and improve the safety and efficacy of patient candidate selection for ocular injections
Pixium Vision annonce ses résultats financiers du premier semestre 2023 et fait le point sur ses activités
26 oct. 2023 01h00 HE
|
Pixium Vision
Pixium Vision annonce ses résultats financiers du premier semestre 2023 et fait le point sur ses activités Événements ultérieurs à la période : obtention d’une avance en compte courant...
Pixium Vision announces its financial results for H1 2023 and provides update
26 oct. 2023 01h00 HE
|
Pixium Vision
Pixium Vision announces its financial results for H1 2023 and provides update Post period event: Received shareholder loan of €3 million from BPIFrance and Sofinnova. Extension of the maturity of...